Pharmacokinetic and exposure-response analysis of pertuzumab in patients with HER2-positive metastatic gastric or gastroesophageal junction cancer.
- Published in:
- 2019
- By:
- Publication type:
- journal article
Works by Nijem, Ihsan
Results: 11
1
2
Pharmacokinetic and exploratory exposure-response analysis of pertuzumab in patients with operable HER2-positive early breast cancer in the APHINITY study.
- Published in:
- 2019
- By:
- Publication type:
- journal article
3
Pharmacokinetic and exposure-response analyses of pertuzumab in combination with trastuzumab and docetaxel during neoadjuvant treatment of HER2+ early breast cancer.
- Published in:
- 2017
- By:
- Publication type:
- journal article
4
Ethnic sensitivity assessment of the antibody-drug conjugate trastuzumab emtansine (T-DM1) in patients with HER2-positive locally advanced or metastatic breast cancer.
- Published in:
- 2016
- By:
- Publication type:
- journal article
5
Addressing Clinical Challenges in Aberrant Pharmacokinetics of Biologic Therapeutic Drugs: Investigating Sample Processing Procedure in the Immunoassays.
- Published in:
- AAPS Journal, 2025, v. 27, n. 2, p. 1, doi. 10.1208/s12248-025-01036-7
- By:
- Publication type:
- Article
6
Implementation of a Three-Way Comparability Assessment for a Bioanalytical Anti-Drug Antibody Method.
- Published in:
- AAPS Journal, 2024, v. 26, n. 3, p. 1, doi. 10.1208/s12248-024-00917-7
- By:
- Publication type:
- Article
7
A Phase I Pharmacokinetic Study of Trastuzumab Emtansine (T-DM1) in Patients with Human Epidermal Growth Factor Receptor 2-Positive Metastatic Breast Cancer and Normal or Reduced Hepatic Function.
- Published in:
- 2017
- By:
- Publication type:
- journal article
8
Placental and Fetal Effects of Onartuzumab, a Met/HGF Signaling Antagonist, When Administered to Pregnant Cynomolgus Monkeys.
- Published in:
- Toxicological Sciences, 2018, v. 165, n. 1, p. 186, doi. 10.1093/toxsci/kfy141
- By:
- Publication type:
- Article
9
Development of a Subcutaneous Fixed‐Dose Combination of Pertuzumab and Trastuzumab: Results From the Phase Ib Dose‐Finding Study.
- Published in:
- Journal of Clinical Pharmacology, 2019, v. 59, n. 5, p. 702, doi. 10.1002/jcph.1362
- By:
- Publication type:
- Article
10
Population pharmacokinetic analysis from phase I and phase II studies of the humanized monovalent antibody, onartuzumab (MetMAb), in patients with advanced solid tumors.
- Published in:
- Journal of Clinical Pharmacology, 2013, v. 53, n. 11, p. 1103, doi. 10.1002/jcph.148
- By:
- Publication type:
- Article
11
Impact of SPR biosensor assay configuration on antibody: Neonatal Fc receptor binding data.
- Published in:
- mAbs (1942-0862), 2017, v. 9, n. 2, p. 319, doi. 10.1080/19420862.2016.1261774
- By:
- Publication type:
- Article